The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma

OBJECTIVES: Thither is a more pressing effort to think about chemotherapy (CTx) in second-line and beyond in patients with metastatic pancreatic cancer (mPC). The current work aimed to evaluate the value of the Glasgow prognostic score (GPS) and modified Glasgow prognostic score (mGPS) to predict th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Amrallah A., Al-Zahrani, Omar, Elsayed, Fifi Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699916/
https://www.ncbi.nlm.nih.gov/pubmed/36447500
http://dx.doi.org/10.25259/IJPC_81_2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699916/
https://www.ncbi.nlm.nih.gov/pubmed/36447500
http://dx.doi.org/10.25259/IJPC_81_2021

Ejemplares similares